Mitch Thelen, PharmD, BCIDP

Erlanger ID

[Mitch Thelen, PharmD, BCIDP @mitch_thelen]

@Zaydovudine @gushamilton @BradSpellberg Why/how do you think this is the case? Kind of baffled by this after reading these threads

[Mitch Thelen, PharmD, BCIDP @mitch_thelen]

@DrToddLee @EricTopol @NEJM Almost like saying abstinence from IV drug use is great for reducing Staph aureus bacteremia 🤯

[Mitch Thelen, PharmD, BCIDP @mitch_thelen]

@nph_pharmD As someone else already said, what study do they cite..? This? https://t.co/vmdPmZpjsU

[Michael Calderwood, MD, MPH @CalderwoodMD]

1/2 Dr. Shruti Gohil @UCIrvineHealth presented INSPIRE data on intra-abdominal infections (IAIs) at #IDWeek2024. IAIs involve diverse organs/spaces. Yet, only 1% (+) for MRSA and another 1% (+) for Pseudomonas, despite 63% of patients getting empiric broad-spectrum abx treatment.

[Andrea Sikora @AndreaSikora]

~90% of pharmacy residency projects do not go onto publication

This indicates that we have a process that is not teaching high quality scientific / scholarship methods OR a process that is not in alignment with the true goal (e.g., an understanding of the quality improvement process).

The BEST way to publish is to work with those who have published before.

https://t.co/5NLaf08Foc

@AJHPOfficial @AFlanneryPharmD @ASHPOfficial @ACCP

[Jesse Briscoe, PharmD, BCCCP @JesseBPharmD]

🚨JOB ALERT 🚨
@ErlangerRx is hiring a MICU/NNICU pharmacist!
▪️Level 1 Trauma, Academic Medical Center
▪️Academic & APP rounding teams
▪️PGY1 and PGY2-CC pharmacy residencies
▪️Pulmonary Care Fellowship starting in 2025
Apply here ⬇️
https://t.co/XNEnbFVjVF

[SIDP @SIDPharm]

ASB? Let it be 🙅‍♀️ #SIDP #stewardship #TwitteRx #IDtwitter

[Mitch Thelen, PharmD, BCIDP @mitch_thelen]

Post-residency plans hard launch - Incredibly thankful to be staying at Erlanger after my PGY2!

[Pharmacy Residency Program at Erlanger @ErlangerRx]

We are so lucky to have Dr. Mitch Thelen on our ID team! Welcome to the Erlanger family, Dr. Thelen!

[Brad Spellberg @BradSpellberg]

@AnilMakam No just POET. Heldman et al. was 100% S. aureus and 100% oral (no IV lead in). And of course there was also the French quasi-experimental study, which was 100% S. aureus. Summary Table, and forrest plot with and without the quasi experimental study.
https://t.co/F9Whl4lYvM

[Mitch Thelen, PharmD, BCIDP @mitch_thelen]

Perfect example of how far from benign antibiotics (especially FQs!) are

[Malini 🇵🇸🍉❤️ @alitlstrawberry]

my sister’s bf somehow took antibiotics for the first time in his life at age 29?! he was so afraid to take them, but everyone said “you’ll be fine.” anyway, the antibiotic was ciprofloxacin and it ruptured his achilles tendons bilaterally and disabled him overnight. 😭

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥Just published🔥 @OFIDJournal
By many super 🌟s @SIDPharm
@reagan_kiger @blandman19 @BBookstaver_USC
@IDstewardship et Al
Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022 #idxposts
H/t @accpinfdprn
https://t.co/6mD6cuo9UR

[Todd C. Lee @DrToddLee]

@jeffpears0n @zchagla @jac_amr @skylerstarkel @MelGoodberlet @lifeofbrianrx @HIV_PharmD Yes it is beyond time to ditch gent because in 2024 we never would have accepted it based on the supporting data.

Weak evidence benefit. Proven harms. Primum non nocere.

@DrEmilyMcD @BradSpellberg

https://t.co/JRjnL7J7Vv

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Linezolid had similar rates of clinical cure to vancomycin in a pooled meta-analysis of bacteremic patients from 5 RCTs of infections due to S. aureus (not limited to SAB),although the number of patients with MRSA bacteremia was low (52 of 3228 enrolled patients) #IDXposts #MedEd

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Non-stop infectious diseases learning process
Stay up-to-date in Infectious Diseases
Follow @ABsteward
Shamless self-promotion #IDXposts AKA #IDTwitter #MedEd

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

It has been proposed that doxycycline may be protective against CDI
🆕️✨️✨️Large VAH retrospective analysis
17% decreased risk of CDI was identified with doxycycline compared to azithromycin when used with ceftriaxone for treatment of CAP (P = .03)
https://t.co/gHOHSuY7i9

[Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship]

🔔 Please share, @BHAcademics is recruiting for a PGY2 infectious diseases pharmacy resident.

🤩 9 BCIDP preceptors. 9 preceptors with PGY2 training in ID. Attendance at IDweek, MAD-ID, ASHP MCM, and ECCMID. Exposure to a system with 12 hospitals, >100 outpatient centers, home infusion, infusion centers, community pharmacy, and so much more. I hear the RPD isn’t bad either.

📱Find it at PPS & learn more: https://t.co/pBhhNq4gkY #IDxPosts #TwitteRx

[Katie Cinnamon @KatieCinnamon]

🔥🔥 IDSA cUTI Clinical Guideline Updates:
-UTI definitions updated
-Duration of therapy for cUTI = 7 days for most patients

#IDWeek2023 #IDTwitter #TwitteRx #SIDP2023

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

More reassuring data!
🆕️⚡️⚡️Multi-institutional analysis Short (med 8d ) was non-inferior in terms of clinical outcomes to prolonged (med 15d) -course antibiotics for treatment of pseudomonas aeruginosa BSI in hem-onc pts with FN @BradSpellberg #IDXposts
https://t.co/UqY2ZPeiOZ

[Michael Mina @michaelmina_lab]

Reminder:

We are studying COVID rebound, including Paxlovid rebound.

If you tested positive within the past 2 days, please take a look below

A Fully at-home study that sends everything to your house and compensates $ for your time/energy/participation